- Home
- RDCM vs CATX Comparison
RDCM vs CATX Comparison
Compare RDCM & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- CATX
- Stock Information
- Founded
- RDCM 1985
- CATX 1983
- Country
- RDCM Israel
- CATX United States
- Employees
- RDCM N/A
- CATX N/A
- Industry
- RDCM Computer peripheral equipment
- CATX Medical/Dental Instruments
- Sector
- RDCM Technology
- CATX Health Care
- Exchange
- RDCM Nasdaq
- CATX Nasdaq
- Market Cap
- RDCM 179.7M
- CATX 182.9M
- IPO Year
- RDCM 1997
- CATX N/A
- Fundamental
- Price
- RDCM $12.61
- CATX $2.34
- Analyst Decision
- RDCM Strong Buy
- CATX Strong Buy
- Analyst Count
- RDCM 2
- CATX 10
- Target Price
- RDCM $15.00
- CATX $13.89
- AVG Volume (30 Days)
- RDCM 30.9K
- CATX 619.9K
- Earning Date
- RDCM 05-14-2025
- CATX 05-12-2025
- Dividend Yield
- RDCM N/A
- CATX N/A
- EPS Growth
- RDCM 79.17
- CATX N/A
- EPS
- RDCM 0.43
- CATX N/A
- Revenue
- RDCM $61,009,000.00
- CATX $1,454,000.00
- Revenue This Year
- RDCM $14.93
- CATX N/A
- Revenue Next Year
- RDCM $10.74
- CATX N/A
- P/E Ratio
- RDCM $29.58
- CATX N/A
- Revenue Growth
- RDCM 18.23
- CATX 1.40
- 52 Week Low
- RDCM $8.85
- CATX $1.60
- 52 Week High
- RDCM $15.98
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- RDCM 63.44
- CATX 51.17
- Support Level
- RDCM $11.67
- CATX $2.18
- Resistance Level
- RDCM $12.80
- CATX $2.65
- Average True Range (ATR)
- RDCM 0.55
- CATX 0.16
- MACD
- RDCM 0.20
- CATX 0.02
- Stochastic Oscillator
- RDCM 92.69
- CATX 56.25
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.